DESCRIPTION
With approximately $20 billion in annual sales coming off patent this year (reported in IMS Health’s 2008 Global Pharmaceutical Market and Therapy Forecast, 11/1/07), the stakes in negotiating and maintaining lucrative licensing and collaborations could not be higher. Drug makers need to invest in building product pipelines, and partnering is a key part of R&D strategies for maintaining profits and fighting the plague of competition from generic manufacturers. And with many of the major companies cutting overhead, partnering becomes an even more attractive way for them to jumpstart research while at the same time trimming costs. For biotech firms, this climate provides opportunities for negotiating attractive financial terms, as evidenced in the recent upfront payments of as much as $100 million.
In its 11th installment, ACI’s Advanced Forum on Pharma/Biotech Collaborative Agreements provides you with the unparalleled opportunity to meet, network and learn from experienced practitioners who every day successfully navigate their way through these complex agreements. Featuring business and legal representatives from 17 leading companies and universities, you will hear from them the most effective strategies for tackling the key challenges confronting you daily when negotiating and drafting agreements, including:
· Retaining valuable product rights
· Securing licenses without granting potentially lucrative co-development options
· Factoring M&A into ANY negotiation
· Drafting clauses creating favorable exclusivity rights and minimizing litigation in the wake of MedImmune and Quanta
· Selecting the right partners, deal structure, and compensation analysis
· Negotiating competitive terms with academic institutions
Continue your conference experience by attending one of the Master Classes:
· Sustaining a Successful Collaboration Through Effective Alliance Management
· The "Win-Win" Collaborative Agreement: Practical and Ethical Negotiating and Drafting Strategies
This year's program will provide the opportunity to continue your discussions with colleagues and speakers at the close of the first day, in a relaxed environment over cocktails. With so much at stake and the ability to network with the outstanding faculty and participants, you can see why many industry professionals return to this event year after year.
Foley Hoag Attorney
Beth Arnold will be speaking on the second day in a session titled
"Setting the Stage for Success by Choosing the Right Partner and Conducting Effective Due Diligence."